| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 24, 2019 | LLY Eli Lilly & Co | Tai Jackson P | Director | Buy | 1,861 | $107.49 | $200,038.89 | +3.4% | |
| Oct 24, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 64,580 | $0.40 | $25,712.00 | - | |
| Oct 23, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Hudson Executive Capital LP49 | Director | Sell | 10,616 | $62.63 | $664,924.34 | -0.5% | |
| Oct 20, 2019 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 1,714 | $5.56 | $9,526.19 | +1.0% | |
| Oct 19, 2019 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth55 | Director | Buy | 1,338 | $5.65 | $7,555.03 | - | |
| Oct 18, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Hudson Executive Capital LP49 | Director | Sell | 15,544 | $62.58 | $972,745.45 | -0.7% | |
| Oct 18, 2019 | CPIX Cumberland Pharmaceuticals Inc | Kazimi A J59 | Chairman And CEO | Buy | 1,174 | $5.65 | $6,638.90 | - | |
| Oct 18, 2019 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 1,174 | $5.65 | $6,638.90 | +0.4% | |
| Oct 16, 2019 | LNTH Lantheus Holdings, Inc. | Marshall Robert J. Jr.53 | CFO And Treasurer | Sell | 4,809 | $19.07 | $91,698.01 | -7.4% | |
| Oct 15, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Hudson Executive Capital LP49 | Director | Sell | 28,038 | $60.64 | $1,700,256.89 | -1.2% | |
| Oct 14, 2019 | ZTS Zoetis Inc. | Lewis Clinton A. Jr.46 | Executive Vice President | Sell | 6,123 | $128.62 | $787,540.26 | -15.6% | |
| Oct 14, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 5,000 | $9.32 | $46,600.00 | +0.2% | |
| Oct 14, 2019 | NBIX Neurocrine Biosciences Inc | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 9,956 | $90.85 | $904,486.67 | -33.7% | |
| Oct 10, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 5,000 | $9.67 | $48,350.00 | +0.2% | |
| Oct 8, 2019 | TAK Takeda Pharmaceutical Co Ltd | Takeda Pharmaceutical Co Ltd70 | 10% Owner | Buy | 2,000,000 | $2.50 | $5,000,000.00 | +53.3% | |
| Oct 8, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 10,000 | $9.96 | $99,600.00 | +0.4% | |
| Oct 8, 2019 | CPMD Cannapharmarx, Inc. | Colvin Dominic | Chief Executive Officer | Sell | 1,000,000 | $0.25 | $250,000.00 | -12.5% | |
| Oct 8, 2019 | ETST Earth Science Tech, Inc. | Majorca Group, Ltd. | 10% Owner | Sell | 129,620 | $0.40 | $51,848.00 | -0.5% | |
| Oct 8, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Hudson Executive Capital LP49 | Director | Sell | 6,459 | $60.09 | $388,119.33 | -0.4% | |
| Oct 8, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 65,334 | $0.41 | $26,460.28 | - | |
| Oct 7, 2019 | AZN Astrazeneca Plc | Astrazeneca Plc | 10% Owner | Buy | 425,000 | $19.00 | $8,075,000.00 | +3.0% | |
| Oct 7, 2019 | HROW Harrow, Inc. | Kammer Robert J | Director | Sell | 6,500 | $5.25 | $34,125.00 | -0.8% | |
| Oct 7, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 8,000 | $10.14 | $81,120.00 | +0.3% | |
| Oct 4, 2019 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 7,000 | $10.40 | $72,800.00 | +0.2% | |
| Oct 2, 2019 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 987 | $88.56 | $87,408.72 | -23.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.